The expression of c-Myc and Bcl-2 proteins has been described in a significant portion of PCNS DLBCL, respectively, up to 70–90% [35,36] and 59–73% [39,40,41] of cases. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.